• Article highlight
  • Article tables
  • Article images

Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 1147

PDF Downloaded: 824


Get Permission Nagar, Khandelwal, Goyal, Pareek, and Bharti: Comparing anaesthetic effects of intrathecal 2- Chloroprocaine with or without fentanyl in ambulatory surgeries- A prospective and randomized control study


Introduction

Short duration lower abdominal and lower limb surgeries are being done increasingly on ambulatory basis. An ideal anaesthetic for spinal anaesthesia in ambulatory surgeries would offer rapid onset of action, adequate potency, anticipated duration, and low incidence of side effects.

2-Chloroprocaine can be a better choice for ambulatory procedures.1 2-Chloroprocaine [benzoic acid, 4-amino-2-chloro-2-(diethylamino) ethyl ester, monohydrochloride] is an amino ester type of local anesthetic that was introduced by Foldes and Mc Nall in 1952.2

In the early 1980s, concerns about its use were raised following the description of nine cases of neurotoxicity after injecting large volumes of epidural 2-chloroprocaine.3, 4, 5 Four out of nine patients were known to have unintentional intrathecal injections. The formulations of 2-chloroprocaine used at that time (Nescaine- CE) contained 0.2% sodium bisulfite as an antioxidant. In the literature, multiple studies have suggested that a combination of a low pH (<3) and presence of sodium bisulfite in the anesthetic preparations, were the main culprits for the neurotoxicity observed.6, 7, 8, 9 Subsequently 2-Chloroprocaine was reintroduced for spinal anaesthesia in a preservative free and antioxidant free form and the pH of the solution was improved. This new formulation has been used at doses ranging from 30 to 60mg, which provides a spinal block profile similar to that of lidocaine in healthy volunteers and surgical patients and have not reported any case of neurological toxicity.10, 11, 12, 13, 14, 15, 16

The addition of intrathecal fentanyl has been used to prolong sensory blockage without delaying motor recovery.17, 18

Thus, aim of our study was to compare the anaesthetic effect of intrathecal 2-Chloroprocaine with or without fentanyl in patients undergoing short duration lower abdominal and lower limb surgeries in ambulatory settings in terms of mean duration of block, hemodynamic parameters, time to ambulation, time to first analgesic dose and side effects.

Materials and Methods

Diagram 1

Consort 2010 flow diagram

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/661b8c74-cb3d-42ee-bd3e-3df2e010a497/image/7dc40e77-472d-4899-a0d1-eb1837d16903-uimage.png

After obtaining the approval by ethical committee of hospital and informed consent, 120 patients, aged 18 to 70 years, body weight >50 kg and ASA physical status I-II patients, undergoing elective lower abdominal and lower limb surgeries with expected duration of <60 mins in Anaesthesia Department at Narayana Multispeciality Hospital, Jaipur, Rajasthan were studied prospectively. Patients with ASA grade -III and IV, known allergy or sensitivity to study group drugs, failed blocks (if complete sensory and motor block not achieved in 20 minutes), known pseudo choline esterase deficiency or atypical pseudo choline esterase disease and other contraindications of subarachnoid block were excluded.

Before the scheduled surgery, pre-anaesthetic evaluation was done and Numeric Rating Scale for pain score on 0-10 were explained to the patient. In the operating room pre-operative vitals were recorded. Patients were divided into two groups (group C & F) and randomization was done by computer generated random number table. Under all aseptic condition, sub-arachnoid block was performed at the L3-L4 space via midline approach using 27G quincke's spinal needle. Patients in Group C received intrathecal inj. 1% 2-Chloroprocaine 4ml with 0.5ml normal saline and Group F received inj. 1% 2-Chloroprocaine 4ml with inj. Fentanyl 25 µg- 0.5ml. Patients were immediately laid supine for the remaining duration of the study as per protocol.

After spinal injection, a blinded assessor recorded the evolution of spinal block until achievement of complete recovery of block. Heart rate, mean blood pressure, respiratory rate, oxygen saturation and Modified Wilson sedation score were recorded at different time intervals till the complete recovery of block.

Sensory block was assessed using loss of pinprick sensation (blunt needle) in caudal to cephalad direction. The right C5 – C6 dermatome used as unblocked reference point. Time to onset (in minutes) was taken as time to onset of sensory block at S2 dermatome, Time to achieve peak block height was taken as the duration of time in minutes to achieve maximum dermatomal level of sensory block, Time to complete sensory recovery was taken as the duration of time (in minutes) from the onset time of sensory block till the time of recovery of S2 dermatome.

Motor block was assessed using a 4-point Modified Bromage score. Onset time in minutes (modified bromage grade =I), time to achieve complete motor block in minutes (grade =III) and time to complete recovery motor in minutes (grade =0). Time to ambulation (in minutes) was taken as when the patient was ambulated after complete recovery of block. Time to 1st post- operative analgesic dose (in minutes) was also noted which was given on the basis of Numeric rating scale for pain score ≥3.

Side effects observed were nausea, vomiting, hypotension (decrease in systolic arterial blood pressure ≥30% of baseline), bradycardia (defined as a decrease in heart rate below 45 beats per minute), respiratory depression, pruritus and local anesthetics toxicity. Patients were followed up for symptoms of headache, backache and TNS (Transient Neurological Symptoms).

Statistics

Sample size is calculated at 95% confidence level and alpha error 0.05 assuming expected standard deviation of 9 minutes in the time of ambulation within the two group as per reference article (spinal 2- Chloroprocaine: the added effect of fentanyl) to detect at least a difference of 5 minutes in the time of ambulation between the two groups. At study power of 80% required sample size of 52 cases in each group and considering 10% of the dropout a total of 60 cases were enrolled in each group.

Descriptive and Inferential statistical analysis was carried out in the present study using computer software (SPSS Trial version 23 and primer). Chi square test and unpaired student T Test was used at confidence level of 95% (p< 0.05).

Results

No statistically significant differences in age, gender distribution, ASA (American Society of Anesthesiologists) physical status and anthropometric variables were noted between the two groups (Table 1). The mean heart rate, mean blood pressure showed a gradual reduction during first 20-30 minutes in both the groups under the effect of neuraxial block and difference was statistically insignificant (P value > 0.05). No statistically significant difference was observed in respiratory rate, oxygen saturation and sedation score among the groups.

Figure 1

Comparison of distribution of the cases according to sensory block- peak block height

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/661b8c74-cb3d-42ee-bd3e-3df2e010a497/image/68aa17e6-a67e-4faa-b43b-0fb22586af43-uimage.png

Spinal anaesthesia was successful for all patients. Peak Block Height was higher in Chloroprocaine with fentanyl group (Figure 2) but it was statistically insignificant (P value = 1.000).

Table 1

Comparison of distribution of demographic data and outcome variables among the groups

Demographic Data

Group C (2-CP with Saline)

Group F (2- CP with Fentanyl)

P Value Level of Significance

Age (years- mean ± SD)

46.28±15.35

44.22±16.32

0.46 NS

Gender (No.- Male/Female)

20/40

21/39

1.000 NS

Weight (Kg- mean ± SD)

70.80±9.070

71.85± 9.704

0.542 NS

Height (cm-mean ± SD)

160.13±8.711

159.35±6.000

0.567 NS

BMI (Kg/m2- mean ± SD)

27.72±3.90

28.31±3.63

0.39 NS

ASA physical status (No.- I/II)

30/30

40/20

0.096 NS

Outcome

Mean ±Std. Deviation

Mean ± Std. Deviation

P value-level of significance

Sensory block (in minutes)

Onset Time

2.22±1.059

2.47±1.214

0.232 NS

Time to achieve peak block height

6.68±1.953

6.72±1.992

0.926 NS

Time to complete sensory recovery

69.17 ± 4.435

105.87 ± 13.398

<0.001S

Motor Block Duration (in minutes)

Onset Time

3.73±1.635

3.80±1.505

0.82 NS

Time to Achieve Complete Motor Block

8.28±1.941

8.12±2.009

0.645 NS

Time to Complete Motor Recovery

64.80 ± 5.138

80.13 ± 10.009

<0.001S

Time To Ambulation

69.17±4.435

105.87±13.398

<0.001S

Time To 1st analgesic dose

59.97 ± 7.576

96.02 ± 13.515

<0.001S

No significant difference was observed among both groups in onset time (p= 0.232NS) and time to achieve peak block height (p= 0.926NS) in sensory block and onset time (p=0.82NS) and time to achieve complete block in motor block (p=0.645 NS) (Table 1).

Figure 2

Comparison of sensory and motor block variables

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/661b8c74-cb3d-42ee-bd3e-3df2e010a497/image/68dfa514-5c7d-4d8d-b427-2bb324cd093e-uimage.png

The mean duration of sensory block as Time to complete sensory recovery was stastically significant longer in Chloroprocaine with Fentanyl group (105.87 ± 13.398 minutes) as compared to Chloroprocaine with Normal Saline group (69.17 ± 4.435 minutes) (Table 1 & Figure 3) (P value<0.001).

The mean duration of motor block as Time to complete motor recovery was stastically significant longer in Chloroprocaine with Fentanyl group (80.13 ± 10.009 min) as compared to Chloroprocaine with Normal Saline group (64.80 ± 5.138 min) and was significant (Table 1 & Figure 3) (P value<0.001).

Among the side effects it was observed that both the groups had episodes of hypotension (p=0.714 NS) and bradycardia (p= 1.0) which were statistically not significant, but pruritus was significantly seen in Fentanyl group (p= 0.036) (Table 2).

Table 2

Comparison of side effects observed among the two groups

Side Effects Observed

Group C

Group F

Grand Total

P Value LS

No

%

No

%

No

%

Hypotension

3

5.00

5

8.33

8

6.67

0.714 NS

Bradycardia

3

5.00

4

6.67

7

5.83

1.0 NS

Nausea and Vomiting

0

0.00

0

0.00

0

0.00

NA

Pruritus

0

0.00

6

10.00

6

5.00

0.036S

Respiratory Depression

0

0.00

0

0.00

0

0.00

NA

Headache, Backache and TNS

0

0.00

0

0.00

0

0.00

NA

Disscussion

Spinal anaesthesia with 2- Chloroprocaine in comparison with general anaesthesia leads to significantly earlier discharge makes it a safe and favourable choice over general anaesthesia (Gebhardt V et al 19 2018, Camponovo C et al202014).21

2-Chloroprocaine is a short acting drug, thus allows rapid recovery of sensory/motor function, and effective alternative to Lidocaine for ambulatory surgeries without transient neurological symptoms. Similar results were found in the study by Breebaart MB et al22 (2014), Goldblum E et al6 (2013), Vaghadia H et al23 (2012), Hejtmanek MR et al.24 (2011), Casati A et al 15 (2007), Kouri ME et al10 (2004). When 2- Chloropocaine was compared to Bupivacaine same results were found as discharge time, duration of block and time to ambulation was shorter with 2- Chloroprocaine (Lacasse MA et al.25 - 2011), Teunkens A et al26 - 2016).

All the demographic characteristics and ASA grading were comparable in both the groups (p >0.05).

The primary finding of this study is that the addition of 25 µg of intrathecal fentanyl to 2-Chloroprocaine spinal anaesthesia prolongs sensory blockade but only minimally lengthens motor blockade.

In our study peak block height was higher in Fentanyl group in comparison with Chloroprocaine with Normal Saline but it was statistically insignificant (p=1.000). These findings were consistent with the study by Vath JS et al27 (2004) and Chaudhary A et al28 (2014) which showed increase in peak block height when Fentanyl was used with Chloroprocaine and Ropivacaine respectively.

Adding of Fentanyl to local anaesthetic did not increase onset time of sensory/motor block, time to achieve peak block height in sensory block, time to achieve complete motor block in our study. (P value > 0.05). Our results were consistent with Vath JS et al27 (2004). Singh H et al29 (1995), Chaudhary A et al28 (2014).

The supplementation of intrathecal Fentanyl as an adjuvant to Chloroprocaine in appropriate dose produce good level of sensory block in all patients and addition of Fentanyl to Chloroprocaine prolongs duration of sensory block with less alteration in motor block. The similar results were found when addition of fentanyl to Chloroprocaine (Vath JS et al27 -2004), bupivacaine (Singh H et al29 -1995) and Kuusniemi KS et al30 2000) and lidocaine (Liu S et al17 -1995) was done.

Time to Ambulation was delayed in Group F as compared with Group C which was stastically significant (P<0.001). The result of our study was consistent with Vath JS et al27 (2004).

In our study Time to first Analgesic Dose was significantly delayed in Chloroprocaine with Fentanyl group (P<0.001). Similar results was found in Singh H et al29 (1995) who found intrathecal fentanyl reduced the analgesic requirement in the early postoperative period following Bupivacaine spinal block.

Limitation of our study was that we have compared only single dose of fentanyl with Chloroprocaine by which we can decide that addition of fentanyl is better for post-operative analgesia, but we cannot find out optimum dose of fentanyl for post- operative analgesia.

Conclusion

In our study, we found that spinal anaesthesia with 2-Chloroprocaine provides faster onset, predictable duration in terms of recovery of sensory and motor block as well as adequate potency for use in ambulatory procedures lasting for less than 60 minutes. Our study suggests that supplementation of intrathecal fentanyl as an adjuvant to Chloroprocaine in appropriate dose is an appealing choice for spinal anaesthesia for short duration surgeries in the ambulatory settings without affecting hemodynamic and respiratory parameters.

Source of Funding

None.

Conflict of Interest

None.

Acknowledgement

We want to thank Dr. Vinay K Gupta, Dr. Vishnu K Gupta (Acedemic and Research Department) and Opertion Theatre Team for their unconditional valuable support.

References

1 

J G Förster Short-acting spinal anesthesia in the ambulatory settingCurr Opin Anaesthesiol20142759760410.1097/aco.0000000000000126

2 

F F Foldes P G McNall 2-chloroprocaine: a new local anesthetic agentAnesthesiol19521332879610.1097/00000542-195205000-00009

3 

L S Reisner B N Hochman M H Plumer Persistent Neurologic Deficit and Adhesive Arachnoiditis following Intrathecal 2-Chloroprocaine InjectionAnesth Analg1980596452410.1213/00000539-198006000-00014

4 

R S Ravindran V K Bond M D Tasch C D Gupta T G Luerssen Prolonged Neural Blockade following Regional Analgesia with 2-ChloroprocaineAnesth Analg19805964475110.1213/00000539-198006000-00013

5 

D C Moore J Spierdijk J D vanKleef R L Coleman G F Love Chloroprocaine neurotoxicity: four additional casesAnesth Analg1982612155910.1213/00000539-198202000-00019

6 

E Goldblum A Atchabahian The use of 2-chloroprocaine for spinal anaesthesiaActa Anaesthesiol Scand20135755455210.1111/aas.12071

7 

A J Gissen S Datta D Lambert The chloroprocaine controversy. II. Is chloroprocaine neurotoxic?Reg Anesth1984913544

8 

K Drasner Chloroprocaine Spinal Anesthesia: Back to the Future?Anesth Analg20051005495210.1213/01.ane.0000143382.89888.c3

9 

B C Wang D E Hillman N I Spielholz H Turndorf Chronic Neurological Deficits and Nesacaine-CE-An Effect of the Anesthetic, 2-Chloroprocaine, or the Antioxidant, Sodium Bisulfite?Anesth Analg1984634445710.1213/00000539-198404000-00013

10 

M E Kouri D J Kopacz Spinal 2-chloroprocaine: a comparison with lidocaine in volunteersAnesth Analg20049817580

11 

K N Smith D J Kopacz S B Mcdonald Spinal 2-chloroprocaine: a dose-ranging study and the effect of added epinephrineAnesth Analg2004981818

12 

P Timo Four years experience with 1% chloroprocaine for spinal anesthesia in ambulatory anesthesiaReg Anesth Pain Med200530160

13 

J R Yoos D J Kopacz Spinal 2-Chloroprocaine for Surgery: An Initial 10-Month ExperienceAnesth Analg2005100553810.1213/01.ane.0000130397.38849.4a

14 

D J Kopacz Spinal 2-chloroprocaine: minimum effective doseReg Anesth Pain Med2005301364210.1016/j.rapm.2004.09.008

15 

A Casati G Fanelli G Danelli M Berti D Ghisi M Brivio Spinal Anesthesia with Lidocaine or Preservative-Free 2-Chlorprocaine for Outpatient Knee Arthroscopy: A Prospective, Randomized, Double-Blind ComparisonAnesth Analg20071049596410.1213/01.ane.0000258766.73612.d8

16 

A Casati G Danelli M Berti A Fioro A Fanelli C Benassi Intrathecal 2-Chloroprocaine for Lower Limb Outpatient Surgery: A Prospective, Randomized, Double-Blind, Clinical EvaluationAnesth Analg2006103234810.1213/01.ane.0000221441.44387.82

17 

S Liu A A Chiu R L Carpenter M F Mulroy H W Allen J M Neal Fentanyl prolongs lidocaine spinal anesthesia without prolonging recoveryAnesth Analg19958047304

18 

B B David E Solomon H Levin H Admoni Z Goldik Intrathecal fentanyl with small-dose dilute bupivacaine: better anesthesia without prolonging recoveryAnesth Analg1997853560510.1097/00000539-199709000-00014

19 

V Gebhardt V Zawierucha O Schöffski A Schwarz C Weiss M D Schmittner Spinal anaesthesia with chloroprocaine 1% versus total intravenous anaesthesia for outpatient knee arthroscopyEur J Anaesthesiol201835107748110.1097/eja.0000000000000794

20 

C Camponovo Spinal 1% 2-Chloroprocaine versus general anesthesia for ultra-short outpatient procedures: a retrospective analysisActa Biomed20148532658

21 

M B Breebaart A Teune L A Sermeus M P Vercauteren Intrathecal chloroprocaine vs. lidocaine in day-case surgery: recovery, discharge and effect of pre-hydration on micturitionActa Anaesthesiol Scand20145822061310.1111/aas.12247

22 

H Vaghadia G Neilson P H Lennox Selective spinal anesthesia for outpatient transurethral prostatectomy (TURP): randomized controlled comparison of chloroprocaine with lidocaineActa Anaesthesiol Scand20125622172310.1111/j.1399-6576.2011.02599.x

23 

M R Hejtmanek J E Pollock Chloroprocaine for spinal anesthesia: a retrospective analysisActa Anaesthesiol Scand20115532677210.1111/j.1399-6576.2010.02371.x

24 

M A e Lacasse J D Roy J Forget F Vandenbroucke R F Seal D Beaulieu Comparison of bupivacaine and 2-chloroprocaine for spinal anesthesia for outpatient surgery: a double-blind randomized trialCan J Anesth20115843849110.1007/s12630-010-9450-x

25 

A Teunkens K Vermeulen E Van Gerven S Fieuws M Van de Velde S Rex Comparison of 2-Chloroprocaine, Bupivacaine, and Lidocaine for Spinal Anesthesia in Patients Undergoing Knee Arthroscopy in an Outpatient SettingReg Anesth Pain Med2016415768310.1097/aap.0000000000000420

26 

J S Vath D J Kopacz Spinal 2-chloroprocaine: the effect of added fentanylAnesth Analg20049818994

27 

A Chaudhary J Bogra PK Singh S Saxena G Chandra R Verma Efficacy of spinal ropivacaine versus ropivacaine with fentanyl in transurethral resection operationsSaudi J Anaesth201488810.4103/1658-354x.125951

28 

H Singh J Yang K Thornton A H Giesecke Intrathecal fentanyl prolongs sensory bupivacaine spinal blockCan J Anaesth1995429879110.1007/bf03011070

29 

K S Kuusniemi K K Pihlajamäki M T Pitkänen H Y Helenius O A Kirvelä The Use of Bupivacaine and Fentanyl for Spinal Anesthesia for Urologic SurgeryAnesth Analg2000911452610.1097/00000539-200012000-00029



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.